Home
TCG Crossover GP II reported a 6.4% stake in LB Pharmaceuticals LBRX · 1,839,489 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.4%
- Last report
- 7.8% · filed 25/09/18
- Shares held
- 1,839,489 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- TCG Crossover GP II
- Event date
- 26/03/31
- Filed
- 26/05/15
6.4% stake · −1.4pp from the last report
- Stake
- 6.4%
- Last report
- 7.8%
- Since last report
- −1.4pp
LB Pharmaceuticals trades, last 26 weeks
What else happened in LB Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 03/01~04/30TCG Crossover GP II's other 5% stake reports
- TCG Crossover GP II
5% stakeAlx Oncology Holdings
5% stakeAlx Oncology Holdings
ALXO
4.2% stake
5,655,487 sh
4.2% stake
Filed 08/14
- TCG Crossover GP II
5% stakeFirst Tracks Biotherapeutics
5% stakeFirst Tracks Biotherapeutics
TRAX
8.3% stake
2,895,304 sh
8.3% stake
Filed 08/14
- TCG Crossover GP II
5% stakeFulcrum Therapeutics
5% stakeFulcrum Therapeutics
FULC
0% stake
0 sh
0% stake
Filed 08/14
- TCG Crossover GP II
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
5% stake
1,447,310 sh
5% stake
Filed 08/14
- TCG Crossover GP II
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
7% stake
10,147,867 sh
7% stake
Filed 08/14
